Myeloma presenting during pregnancy

Hematol Oncol. 2014 Mar;32(1):52-5. doi: 10.1002/hon.2088. Epub 2013 Sep 1.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Boronic Acids / administration & dosage
  • Bortezomib
  • Cesarean Section
  • Chemoradiotherapy
  • Cisplatin / administration & dosage
  • Combined Modality Therapy
  • Contraindications
  • Cyclophosphamide / administration & dosage
  • Cytarabine / administration & dosage
  • Dexamethasone / administration & dosage
  • Dexamethasone / therapeutic use
  • Doxorubicin / administration & dosage
  • Etoposide / administration & dosage
  • Fatal Outcome
  • Female
  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Hypercalcemia / etiology
  • Idarubicin / administration & dosage
  • Infant, Newborn
  • Lenalidomide
  • Male
  • Melphalan / administration & dosage
  • Methylprednisolone / administration & dosage
  • Multiple Myeloma / diagnosis
  • Multiple Myeloma / drug therapy*
  • Myeloma Proteins / analysis
  • Osteolysis / diagnosis
  • Osteolysis / etiology
  • Plasmacytoma / diagnosis
  • Plasmacytoma / genetics
  • Plasmacytoma / therapy*
  • Postpartum Period
  • Pregnancy
  • Pregnancy Complications, Neoplastic / diagnosis
  • Pregnancy Complications, Neoplastic / drug therapy
  • Pregnancy Complications, Neoplastic / therapy*
  • Pregnancy Complications, Neoplastic / urine
  • Pregnancy Outcome
  • Pyrazines / administration & dosage
  • Remission Induction
  • Spinal Cord Compression / etiology
  • Thalidomide / administration & dosage
  • Thalidomide / analogs & derivatives
  • Thoracic Vertebrae / pathology
  • Transplantation, Autologous

Substances

  • Boronic Acids
  • Myeloma Proteins
  • Pyrazines
  • Cytarabine
  • Thalidomide
  • Bortezomib
  • Etoposide
  • Dexamethasone
  • Doxorubicin
  • Cyclophosphamide
  • Lenalidomide
  • Cisplatin
  • Melphalan
  • Methylprednisolone
  • Idarubicin